Whereas IFNγ and TNF are canonical pro-inflammatory cytokines, IL-2 has attained a more dichotomous role in cancer immunotherapy, with T cell stimulatory capacities on one hand and immunosuppressive characteristics on the other hand. This evidence concerns the gene IFNG and cancer.